Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.

Hussein, Ayad Ahmed

Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. [electronic resource] - Pediatric blood & cancer Aug 2013 - 1345-9 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article

1545-5017

10.1002/pbc.24493 doi


Adolescent
Adult
Antilymphocyte Serum--administration & dosage
Busulfan--administration & dosage
Child
Child, Preschool
Cyclophosphamide--administration & dosage
Disease-Free Survival
Female
Follow-Up Studies
Graft Rejection--etiology
Graft Survival
Hematopoietic Stem Cell Transplantation
Humans
Immunologic Factors--administration & dosage
Infant
Male
Myeloablative Agonists--administration & dosage
Retrospective Studies
Risk Factors
Survival Rate
Tissue Donors
Transplantation Conditioning--methods
Transplantation, Homologous
Vidarabine--administration & dosage
beta-Thalassemia--mortality